Intervention Protocol

Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease

  1. Ying Wang1,*,
  2. Jessica N Ivany1,
  3. Vlado Perkovic2,
  4. Martin P Gallagher2,
  5. Meg J Jardine1

Editorial Group: Cochrane Kidney and Transplant Group

Published Online: 15 FEB 2012

DOI: 10.1002/14651858.CD009631


How to Cite

Wang Y, Ivany JN, Perkovic V, Gallagher MP, Jardine MJ. Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 2. Art. No.: CD009631. DOI: 10.1002/14651858.CD009631.

Author Information

  1. 1

    Concord Repatriation General Hospital, Department of Renal Medicine, Concord, NSW, Australia

  2. 2

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, NSW, Australia

*Ying Wang, Department of Renal Medicine, Concord Repatriation General Hospital, Hospital Road, Concord, NSW, 2139, Australia. yiying_wang@hotmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 15 FEB 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

This review aims to compare the prophylactic effect of different anticoagulant agents, preparations, doses and administration on the incidence of central venous haemodialysis catheter-related malfunction and sepsis in patients with ESKD.